Newsroom
Sorted by: Latest
-
Riassunto: BeOne Medicines evidenzia la leadership oncologica globale alla 44a Annual Healthcare Conference di J.P. Morgan
SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), società oncologica globale, evidenzierà i pilastri della sua crescente leadership oncologica globale durante la sua presentazione oggi alla 44a Annual Healthcare Conference di J.P. Morgan a San Francisco. John V. Oyler, Cofondatore, Presidente e CEO di BeOne, evidenzierà la leadership innovativa della Società nella terapia dei tumori maligni a cellule B. La presentazione includerà BRUKINSA®, l'ini...
-
BeOne Medicines demonstriert seine globale Marktführerschaft im Bereich Onkologie auf der 44. jährlichen J.P. Morgan Healthcare Conference
SAN CARLOS, Kalifornien--(BUSINESS WIRE)--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), ein weltweit tätiges Onkologieunternehmen, wird im Rahmen seiner heutigen Präsentation auf der 44. jährlichen J.P. Morgan Healthcare Conference in San Francisco die Grundpfeiler seiner zunehmenden globalen Führungsrolle auf dem Gebiet der Onkologie vorstellen. John V. Oyler, Mitbegründer, Chairman und CEO von BeOne, wird die transformative Vorreiterrolle des Unternehmens bei der Behandlung vo...
-
Citibank UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- Re: Bausch+Lomb Netherlands B.V. EUR 651,827,000.00 MATURING: 15-Jan-2031 ISIN: XS3102032201 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 15-Jan-2026 TO 15-Apr-2026 HAS BEEN FIXED AT 5.89 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 15-Apr-2026 WILL AMOUNT TO: EUR 9,737,086.63 PER EUR 661,150,000.00 DENOMINATION ...
-
BeOne Medicines met en avant son leadership mondial en oncologie lors de la 44e J.P. Morgan Healthcare Conference annuelle
SAN CARLOS, Californie--(BUSINESS WIRE)--BeOne Medicines Ltd. (NASDAQ : ONC ; HKEX : 06160 ; SSE : 688235), une société mondiale spécialisée en oncologie, présentera les piliers de son leadership mondial croissant en oncologie lors de sa présentation aujourd’hui à la 44e J.P. Morgan Healthcare Conference annuelle à San Francisco. John V. Oyler, cofondateur, président-directeur général de BeOne, mettra en avant le leadership transformateur de la société dans le traitement des malignités à cellul...
-
Textio Announces CEO Transition
SAN FRANCISCO--(BUSINESS WIRE)--Textio, a leader in building tools that help high-growth companies recruit and coach high-performing teams, today announced that its board has appointed Colleen Gallagher, currently Chief Operating Officer, as the company’s next Chief Executive Officer. Jensen Harris, Textio’s founding CTO and CEO for the last two years, will return to the CTO role and continue to guide the company’s technical direction, in addition to remaining on the board. Gallagher assumes th...
-
AM Best Assigns Preliminary Credit Assessment to Beazley Bermuda Insurance Limited
LONDON--(BUSINESS WIRE)--AM Best has assigned a Preliminary Credit Assessment (PCA) to Beazley Bermuda Insurance Limited (BBIL) (Bermuda) with a Financial Strength Assessment of A pca (Excellent) and a Long-Term Issuer Credit Assessment of “a+” pca (Excellent). The outlook assigned to the PCA is stable. The PCA reflects BBIL’s balance sheet strength, which AM Best assesses as very strong, as well as its adequate operating performance, neutral business profile and appropriate enterprise risk man...
-
Saba Capital Releases Letter Sent to Workspace Group Plc’s Board of Directors
LONDON--(BUSINESS WIRE)--Saba Capital Management, L.P. (together with certain of its affiliates, “Saba” or “we”), which owns approximately 13.5% of the outstanding share capital of Workspace Group plc (WKP:LSE) (the “Company”), today disclosed that it sent a letter to the Company’s Board of Directors (the “Board”) on 8 January 2026. In the letter, Saba urged the Board to recommend the Company proceed with a managed wind-down, which should include an orderly strategic sale of its assets, systema...
-
MEMSCAP : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE CONTRACTE AVEC LE CREDIT INDUSTRIEL ET COMMERCIAL
GRENOBLE, France--(BUSINESS WIRE)--Regulatory News: Au titre du contrat de liquidité confié par la société MEMSCAP (Euronext Paris : MEMS) au CREDIT INDUSTRIEL ET COMMERCIAL, à la date du 31 décembre 2025, les moyens suivants figuraient au compte de liquidité : 1 750 titres 19 950,03 € Au cours du 2ème semestre 2025, il a été négocié un total de : 81 823 titres à l’achat pour un montant de 327 084,35 € 81 023 titres à la vente pour un montant de 326 120,09 € Sur cette même période, ont été exéc...
-
Sydney Huang Introduces Human API, a Platform Designed to Integrate Human Capabilities into Agent-Driven AI Systems
SAN FRANCISCO--(BUSINESS WIRE)--Sydney Huang, founder and Chief Executive Officer of Eclipse Labs, today announced the launch of Human API, an agent-native platform built to support AI systems that require human involvement to complete real-world tasks and acquire high-fidelity data. As autonomous AI agents become more prevalent across enterprise and research environments, their effectiveness is increasingly limited by real-world constraints. Many tasks that deliver economic value, including co...
-
eMaxx Establishes Reciprocal Insurance Exchange as a Commercial Property and Casualty (Re)Insurer in Arkansas
TAMPA, Fla.--(BUSINESS WIRE)--eMaxx, a Specialty Managing General Agent and Attorney-in-Fact providing commercial property & casualty (re)insurer solutions through policyholder-owned alternative risk insurance programs, has established the eMaxx Reciprocal Insurance Exchange (“Reciprocal”), domiciled in the State of Arkansas. Owned by its policyholder Subscribers, the Reciprocal will provide commercial property and casualty insurance solutions as both a reinsurer and insurer and will suppor...